VISTAGEN THERAPEUTICS
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and disorders involving the central nervous system (CNS). VistaGen's lead product candidate, AV-101, is a next generation, orally available prodrug candidate in Phase 2 development, initially for the adjunctive treatment of Major Depressive Disorder (MDD) in patients with an inadequate response to standard antidepressants.
VISTAGEN THERAPEUTICS
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
1998-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vistagen.com
Total Employee:
11+
Status:
Active
Contact:
6505589566
Email Addresses:
[email protected]
Total Funding:
154.75 M USD
Technology used in webpage:
IPv6 ReCAPTCHA Comcast Network Solutions SSL IHS Markit
Similar Organizations
MGC Pharmaceuticals
MGC Pharmaceuticals is a company founded with vision. A vision of globalizing the arena in which Cannabis, and specifically CBD.
Napa Valley Vintners
NVV is a regional trade association with an active membership of nearly 500 wineries represents a tradition of dedicated vintners and grape.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Proteon Therapeutics
Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-12-21 | Pherin Pharmaceuticals. | Pherin Pharmaceuticals. acquired by VistaGen Therapeutics | N/A |
Investors List
BVF Partners
BVF Partners investment in Post-IPO Equity - VistaGen Therapeutics
TCG Crossover
TCG Crossover investment in Post-IPO Equity - VistaGen Therapeutics
Logos Capital
Logos Capital investment in Post-IPO Equity - VistaGen Therapeutics
Great Point Partners
Great Point Partners investment in Post-IPO Equity - VistaGen Therapeutics
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - VistaGen Therapeutics
Commodore Capital
Commodore Capital investment in Post-IPO Equity - VistaGen Therapeutics
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - VistaGen Therapeutics
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Venture Round - VistaGen Therapeutics
Montaur Capital Partners
Montaur Capital Partners investment in Venture Round - VistaGen Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-08-22 | Vistagen Appoints Cindy Anderson as Chief Financial Officer |
| 2022-05-02 | VistaGen Appoints Reid Adler as Chief Legal Officer |
Official Site Inspections
http://www.vistagen.com Semrush global rank: 6.13 M Semrush visits lastest month: 1.12 K
- Host name: wwwizer.com
- IP address: 174.129.25.170
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "VistaGen Therapeutics"
Vistagen Therapeutics, Inc
Vistagen is developing an innovative pipeline of neuroscience medications with the potential to establish new standards of care in the treatment of multiple psychiatric and neurological …See details»
Our Purpose, Our Vision - Vistagen Therapeutics, Inc
Vistagen Therapeutics’ core goal is to radically improve mental health and well-being worldwide. Beyond our drug development expertise, we strive to improve the mental health care …See details»
Pipeline Overview - Vistagen Therapeutics, Inc
Our CNS pipeline includes three differentiated new generation CNS drug candidates with the potential to go beyond the current standard of care for anxiety, depression and other CNS …See details»
VistaGen Therapeutics - Crunchbase Company Profile & Funding
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and …See details»
VistaGen Therapeutics Org Chart - The Org
VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high …See details»
Vistagen - LinkedIn
Changing the trajectory of mental health care – One Mind at a Time | Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in …See details»
VistaGen Therapeutics, Inc. - AnnualReports.com
VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care …See details»
Vistagen Therapeutics Company Profile 2024: Stock Performance ...
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development …See details»
Vistagen Therapeutics, Inc. (VTGN) Company Profile & Overview
6 days ago · Vistagen Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurological disorders.See details»
Corporate Governance - Vistagen Therapeutics, Inc
Bold opportunities to change the course of mental health care. Our executive team is made up of visionary thinkers and experts, dedicated to positioning Vistagen for long-term success.See details»
VistaGen Therapeutics' Leadership Team - The Org
The leadership team at VistaGen Therapeutics has a wealth of experience in the pharmaceutical industry. They have held positions at some of the biggest names in the business, including …See details»
Vistagen Reports Fiscal Year 2025 First Quarter Financial Results …
Aug 13, 2024 · SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to …See details»
VistaGen Therapeutics - Craft
Sep 6, 2024 · VistaGen Therapeutics is a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system disorders.See details»
Vistagen Therapeutics, Inc. (VTGN) - Yahoo Finance Canada
Vistagen Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurological disorders.See details»
VistaGen Therapeutics Reports Fiscal Year 2022 ... - Business Wire
Jun 23, 2022 · We remain steadfast in pursuit of our mission to improve mental health and well-being for individuals suffering from anxiety, depression and other CNS related disorders …See details»
Board of Directors - Vistagen Therapeutics, Inc
Vistagen Therapeutics Board of Directors includes: Jon S. Saxe, J.D., LL.M, Ann Cunningham, MBA, Joanne Curley, Ph.D., Mary L. Rotunno, J.D., Maggie FitzPatrick, Jerry Gin, Ph.D., …See details»
VistaGen - VentureRadar
VistaGen Therapeutics, Inc. is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of …See details»
Vistagen Reports Fiscal Year 2025 First Quarter Financial
Aug 13, 2024 · Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of …See details»
Press Releases - Vistagen Therapeutics, Inc
Oct 9, 2024 · We’re on the pulse of innovations in mental health treatment. Follow our journey. Stay updated on the latest Vistagen News and get the details about important events, public …See details»
Vistagen Therapeutics, Inc. (VTGN) - Yahoo Finance
Nov 7, 2024 · Vistagen Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurological disorders.See details»